Neoasia Hong Kong Celebrates Launch of Clinical Innovations in Photoprotection & Hair Growth

Neoasia Hong Kong successfully hosted its latest scientific event, “Advances in Clinical Photoprotection & Hair Growth”, on 21 May 2026 at W Hong Kong. The occasion marked an important milestone with the premiere introduction of Heliocare and Nourkrin to the Hong Kong market, bringing advanced, science-backed solutions for skin and hair health to local practitioners.

With a strong global reputation, Heliocare introduces a clinically proven, revolutionary oral photoprotection approach powered by Fernblock®, offering a comprehensive protective mechanism against the sun while helping to strengthen overall skin resilience. Alongside this, Nourkrin brings its next-generation proteoglycan replacement therapy to Hong Kong—a drug-free alternative to conventional hair loss treatments. Supported by clinical data, it offers a credible option for strengthening hair and promoting continuous growth over time.

Honouring Our Esteemed Guests

We were privileged to be joined by distinguished leaders and partners who contributed to the success of the evening. The event was fronted by Mr. Chen Heng Hui, CEO of Neoasia Group, and Ms. Clare Chan, Sales Manager of Neoasia Hong Kong.

We were also delighted to welcome our partners from Cantabria Labs:

• Mr. James Macfarlane, Global Scientific Marketing Project Manager
• Ms. Maria Lopez Trillo, International Key Account Manager

Their presence underscored the strong collaboration between Neoasia and Cantabria Labs in advancing scientifically driven solutions across the region.

Expert Insights and Knowledge Exchange

The scientific programme featured two renowned speakers:

• Dr. Angeline Yong (Singapore), Dermatologist and Dermatological Surgeon
• Dr. Hau Kwun Cheung (Hong Kong), Dermatologist

Through their presentations, they brought valuable regional and clinical perspectives on how photoprotection and hair restoration strategies can be effectively integrated into day-to-day clinical practice.

A Milestone for Hong Kong

The launch of Heliocare and Nourkrin in Hong Kong signifies Neoasia’s continued dedication to introducing evidence-based, high-quality innovations to healthcare professionals in the region. We extend our sincere appreciation to all speakers, partners, and attendees whose participation made this event a success. We look forward to continuing this journey—bringing forward-thinking solutions to empower practitioners and enhance patient outcomes.